Insufficient scRNA-seq data for expression of AOC2 at single-cell level.
Insufficient scRNA-seq data for expression of AOC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 215.42 | 245 / 245 | 71% | 1.52 | 355 / 502 |
brain | 95% | 202.84 | 2502 / 2642 | 72% | 1.54 | 507 / 705 |
bladder | 100% | 246.48 | 21 / 21 | 64% | 3.63 | 323 / 504 |
kidney | 99% | 138.58 | 88 / 89 | 60% | 1.22 | 541 / 901 |
esophagus | 95% | 133.07 | 1372 / 1445 | 63% | 1.53 | 116 / 183 |
lung | 100% | 310.24 | 578 / 578 | 58% | 1.67 | 665 / 1155 |
liver | 100% | 233.62 | 226 / 226 | 54% | 1.21 | 221 / 406 |
uterus | 100% | 190.34 | 170 / 170 | 49% | 1.65 | 226 / 459 |
adrenal gland | 98% | 135.77 | 253 / 258 | 50% | 1.13 | 114 / 230 |
breast | 100% | 344.50 | 459 / 459 | 46% | 1.10 | 510 / 1118 |
ovary | 99% | 140.60 | 178 / 180 | 41% | 0.96 | 175 / 430 |
skin | 91% | 135.22 | 1655 / 1809 | 47% | 1.18 | 224 / 472 |
thymus | 99% | 134.29 | 644 / 653 | 34% | 0.51 | 204 / 605 |
pancreas | 60% | 44.97 | 198 / 328 | 63% | 1.65 | 112 / 178 |
stomach | 84% | 84.56 | 300 / 359 | 28% | 0.52 | 81 / 286 |
intestine | 88% | 135.53 | 852 / 966 | 23% | 0.45 | 121 / 527 |
adipose | 100% | 443.36 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 218.95 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.04 | 1 / 1 |
peripheral blood | 98% | 333.22 | 906 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 95% | 134.88 | 1270 / 1335 | 0% | 0 | 0 / 0 |
muscle | 90% | 123.94 | 719 / 803 | 0% | 0 | 0 / 0 |
heart | 53% | 44.23 | 458 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 38% | 0.70 | 11 / 29 |
eye | 0% | 0 | 0 / 0 | 36% | 2.92 | 29 / 80 |
tonsil | 0% | 0 | 0 / 0 | 29% | 0.55 | 13 / 45 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006584 | Biological process | catecholamine metabolic process |
GO_0007601 | Biological process | visual perception |
GO_0009308 | Biological process | amine metabolic process |
GO_0006805 | Biological process | xenobiotic metabolic process |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005507 | Molecular function | copper ion binding |
GO_0052595 | Molecular function | aliphatic amine oxidase activity |
GO_0048038 | Molecular function | quinone binding |
GO_0005515 | Molecular function | protein binding |
GO_0009055 | Molecular function | electron transfer activity |
GO_0008131 | Molecular function | primary amine oxidase activity |
Gene name | AOC2 |
Protein name | Amine oxidase [copper-containing] 2 (EC 1.4.3.21) (Amine oxidase copper-containing 2) (Retina-specific copper amine oxidase) (RAO) (Semicarbazide-sensitive amine oxidase) (SSAO) |
Synonyms | |
Description | FUNCTION: Catalyzes the oxidative deamination of primary amines to the corresponding aldehydes with the concomitant production of hydrogen peroxide and ammonia . Has a preference for 2-phenylethylamine, tryptamine and tyramine . Could also act on methylamine and benzylamine but much less efficiently . . |
Accessions | ENST00000253799.8 [O75106-1] ENST00000452774.2 [O75106-2] O75106 |